The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Subcutaneous Biologics Market Research Report 2025
Synopsis
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
The global Subcutaneous Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Subcutaneous Biologics in Hospital pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Subcutaneous Biologics include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb and Eisai Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Biologics.
Report Scope
The Subcutaneous Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
Segment by Type
Syringe
Wearable injector
Automatic injector
Implants
Segment by Application
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
The global Subcutaneous Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Subcutaneous Biologics in Hospital pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Subcutaneous Biologics include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb and Eisai Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Biologics.
Report Scope
The Subcutaneous Biologics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
Segment by Type
Syringe
Wearable injector
Automatic injector
Implants
Segment by Application
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Biologics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Biologics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Syringe
1.2.3 Wearable injector
1.2.4 Automatic injector
1.2.5 Implants
1.3 Market by Application
1.3.1 Global Subcutaneous Biologics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital pharmacies
1.3.3 Retail pharmacies
1.3.4 Drug stores
1.3.5 Online pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Biologics Market Perspective (2019-2030)
2.2 Subcutaneous Biologics Growth Trends by Region
2.2.1 Global Subcutaneous Biologics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Subcutaneous Biologics Historic Market Size by Region (2019-2024)
2.2.3 Subcutaneous Biologics Forecasted Market Size by Region (2025-2030)
2.3 Subcutaneous Biologics Market Dynamics
2.3.1 Subcutaneous Biologics Industry Trends
2.3.2 Subcutaneous Biologics Market Drivers
2.3.3 Subcutaneous Biologics Market Challenges
2.3.4 Subcutaneous Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Biologics Players by Revenue
3.1.1 Global Top Subcutaneous Biologics Players by Revenue (2019-2024)
3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2019-2024)
3.2 Global Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Subcutaneous Biologics Revenue
3.4 Global Subcutaneous Biologics Market Concentration Ratio
3.4.1 Global Subcutaneous Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Biologics Revenue in 2023
3.5 Subcutaneous Biologics Key Players Head office and Area Served
3.6 Key Players Subcutaneous Biologics Product Solution and Service
3.7 Date of Enter into Subcutaneous Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Biologics Breakdown Data by Type
4.1 Global Subcutaneous Biologics Historic Market Size by Type (2019-2024)
4.2 Global Subcutaneous Biologics Forecasted Market Size by Type (2025-2030)
5 Subcutaneous Biologics Breakdown Data by Application
5.1 Global Subcutaneous Biologics Historic Market Size by Application (2019-2024)
5.2 Global Subcutaneous Biologics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Subcutaneous Biologics Market Size (2019-2030)
6.2 North America Subcutaneous Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Subcutaneous Biologics Market Size by Country (2019-2024)
6.4 North America Subcutaneous Biologics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Subcutaneous Biologics Market Size (2019-2030)
7.2 Europe Subcutaneous Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Subcutaneous Biologics Market Size by Country (2019-2024)
7.4 Europe Subcutaneous Biologics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Biologics Market Size (2019-2030)
8.2 Asia-Pacific Subcutaneous Biologics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Subcutaneous Biologics Market Size by Region (2019-2024)
8.4 Asia-Pacific Subcutaneous Biologics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Subcutaneous Biologics Market Size (2019-2030)
9.2 Latin America Subcutaneous Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Subcutaneous Biologics Market Size by Country (2019-2024)
9.4 Latin America Subcutaneous Biologics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Biologics Market Size (2019-2030)
10.2 Middle East & Africa Subcutaneous Biologics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Subcutaneous Biologics Market Size by Country (2019-2024)
10.4 Middle East & Africa Subcutaneous Biologics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Subcutaneous Biologics Introduction
11.1.4 Abbott Laboratories Revenue in Subcutaneous Biologics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Subcutaneous Biologics Introduction
11.2.4 Pfizer Inc. Revenue in Subcutaneous Biologics Business (2019-2024)
11.2.5 Pfizer Inc. Recent Development
11.3 Genentech Inc.
11.3.1 Genentech Inc. Company Detail
11.3.2 Genentech Inc. Business Overview
11.3.3 Genentech Inc. Subcutaneous Biologics Introduction
11.3.4 Genentech Inc. Revenue in Subcutaneous Biologics Business (2019-2024)
11.3.5 Genentech Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Subcutaneous Biologics Introduction
11.4.4 Novartis AG Revenue in Subcutaneous Biologics Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Detail
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Subcutaneous Biologics Introduction
11.5.4 Biogen Idec Revenue in Subcutaneous Biologics Business (2019-2024)
11.5.5 Biogen Idec Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Detail
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Subcutaneous Biologics Introduction
11.6.4 AbbVie Inc. Revenue in Subcutaneous Biologics Business (2019-2024)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Detail
11.7.2 F. Hoffmann-La Roche AG Business Overview
11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Introduction
11.7.4 F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2019-2024)
11.7.5 F. Hoffmann-La Roche AG Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Eisai Inc.
11.9.1 Eisai Inc. Company Detail
11.9.2 Eisai Inc. Business Overview
11.9.3 Eisai Inc. Subcutaneous Biologics Introduction
11.9.4 Eisai Inc. Revenue in Subcutaneous Biologics Business (2019-2024)
11.9.5 Eisai Inc. Recent Development
11.10 Takeda Pharmaceuticals Ltd.
11.10.1 Takeda Pharmaceuticals Ltd. Company Detail
11.10.2 Takeda Pharmaceuticals Ltd. Business Overview
11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Introduction
11.10.4 Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2019-2024)
11.10.5 Takeda Pharmaceuticals Ltd. Recent Development
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Detail
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2019-2024)
11.11.5 Alnylam Pharmaceuticals Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Detail
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Subcutaneous Biologics Introduction
11.12.4 Bayer AG Revenue in Subcutaneous Biologics Business (2019-2024)
11.12.5 Bayer AG Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Detail
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Subcutaneous Biologics Introduction
11.13.4 GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2019-2024)
11.13.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Subcutaneous Biologics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Syringe
Table 3. Key Players of Wearable injector
Table 4. Key Players of Automatic injector
Table 5. Key Players of Implants
Table 6. Global Subcutaneous Biologics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Subcutaneous Biologics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Subcutaneous Biologics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Subcutaneous Biologics Market Share by Region (2019-2024)
Table 10. Global Subcutaneous Biologics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Subcutaneous Biologics Market Share by Region (2025-2030)
Table 12. Subcutaneous Biologics Market Trends
Table 13. Subcutaneous Biologics Market Drivers
Table 14. Subcutaneous Biologics Market Challenges
Table 15. Subcutaneous Biologics Market Restraints
Table 16. Global Subcutaneous Biologics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Subcutaneous Biologics Market Share by Players (2019-2024)
Table 18. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Biologics as of 2023)
Table 19. Ranking of Global Top Subcutaneous Biologics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Subcutaneous Biologics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Subcutaneous Biologics Product Solution and Service
Table 23. Date of Enter into Subcutaneous Biologics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Subcutaneous Biologics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Subcutaneous Biologics Revenue Market Share by Type (2019-2024)
Table 27. Global Subcutaneous Biologics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Subcutaneous Biologics Revenue Market Share by Type (2025-2030)
Table 29. Global Subcutaneous Biologics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Subcutaneous Biologics Revenue Market Share by Application (2019-2024)
Table 31. Global Subcutaneous Biologics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Subcutaneous Biologics Revenue Market Share by Application (2025-2030)
Table 33. North America Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Subcutaneous Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Subcutaneous Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Subcutaneous Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Subcutaneous Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Subcutaneous Biologics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Subcutaneous Biologics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Subcutaneous Biologics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Subcutaneous Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Subcutaneous Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Subcutaneous Biologics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Subcutaneous Biologics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Subcutaneous Biologics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Subcutaneous Biologics Product
Table 51. Abbott Laboratories Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Pfizer Inc. Company Detail
Table 54. Pfizer Inc. Business Overview
Table 55. Pfizer Inc. Subcutaneous Biologics Product
Table 56. Pfizer Inc. Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 57. Pfizer Inc. Recent Development
Table 58. Genentech Inc. Company Detail
Table 59. Genentech Inc. Business Overview
Table 60. Genentech Inc. Subcutaneous Biologics Product
Table 61. Genentech Inc. Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 62. Genentech Inc. Recent Development
Table 63. Novartis AG Company Detail
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Subcutaneous Biologics Product
Table 66. Novartis AG Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. Biogen Idec Company Detail
Table 69. Biogen Idec Business Overview
Table 70. Biogen Idec Subcutaneous Biologics Product
Table 71. Biogen Idec Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 72. Biogen Idec Recent Development
Table 73. AbbVie Inc. Company Detail
Table 74. AbbVie Inc. Business Overview
Table 75. AbbVie Inc. Subcutaneous Biologics Product
Table 76. AbbVie Inc. Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 77. AbbVie Inc. Recent Development
Table 78. F. Hoffmann-La Roche AG Company Detail
Table 79. F. Hoffmann-La Roche AG Business Overview
Table 80. F. Hoffmann-La Roche AG Subcutaneous Biologics Product
Table 81. F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 82. F. Hoffmann-La Roche AG Recent Development
Table 83. Bristol-Myers Squibb Company Detail
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Subcutaneous Biologics Product
Table 86. Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Eisai Inc. Company Detail
Table 89. Eisai Inc. Business Overview
Table 90. Eisai Inc. Subcutaneous Biologics Product
Table 91. Eisai Inc. Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 92. Eisai Inc. Recent Development
Table 93. Takeda Pharmaceuticals Ltd. Company Detail
Table 94. Takeda Pharmaceuticals Ltd. Business Overview
Table 95. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product
Table 96. Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 97. Takeda Pharmaceuticals Ltd. Recent Development
Table 98. Alnylam Pharmaceuticals Company Detail
Table 99. Alnylam Pharmaceuticals Business Overview
Table 100. Alnylam Pharmaceuticals Subcutaneous Biologics Product
Table 101. Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 102. Alnylam Pharmaceuticals Recent Development
Table 103. Bayer AG Company Detail
Table 104. Bayer AG Business Overview
Table 105. Bayer AG Subcutaneous Biologics Product
Table 106. Bayer AG Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 107. Bayer AG Recent Development
Table 108. GlaxoSmithKline Company Detail
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Subcutaneous Biologics Product
Table 111. GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2019-2024) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Subcutaneous Biologics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Subcutaneous Biologics Market Share by Type: 2023 VS 2030
Figure 3. Syringe Features
Figure 4. Wearable injector Features
Figure 5. Automatic injector Features
Figure 6. Implants Features
Figure 7. Global Subcutaneous Biologics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Subcutaneous Biologics Market Share by Application: 2023 VS 2030
Figure 9. Hospital pharmacies Case Studies
Figure 10. Retail pharmacies Case Studies
Figure 11. Drug stores Case Studies
Figure 12. Online pharmacies Case Studies
Figure 13. Subcutaneous Biologics Report Years Considered
Figure 14. Global Subcutaneous Biologics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Subcutaneous Biologics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Subcutaneous Biologics Market Share by Region: 2023 VS 2030
Figure 17. Global Subcutaneous Biologics Market Share by Players in 2023
Figure 18. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Biologics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2023
Figure 20. North America Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Subcutaneous Biologics Market Share by Country (2019-2030)
Figure 22. United States Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Subcutaneous Biologics Market Share by Country (2019-2030)
Figure 26. Germany Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Subcutaneous Biologics Market Share by Region (2019-2030)
Figure 34. China Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Subcutaneous Biologics Market Share by Country (2019-2030)
Figure 42. Mexico Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Subcutaneous Biologics Market Share by Country (2019-2030)
Figure 46. Turkey Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Subcutaneous Biologics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 49. Pfizer Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 50. Genentech Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 51. Novartis AG Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 52. Biogen Idec Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 53. AbbVie Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 54. F. Hoffmann-La Roche AG Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 56. Eisai Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 57. Takeda Pharmaceuticals Ltd. Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 59. Bayer AG Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Subcutaneous Biologics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
